EP2887944
Allópregnanólón til meðhöndlunar á þrálátum síflogum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.8.2013EP published:
6.10.2021EP application number:
13830765.7
EP translation filed:
21.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
20.8.2033Expiry date:
20.8.2025
Title:
ALLOPREGNANOLONE FOR TREATING REFRACTORY STATUS EPILEPTICUS
Timeline
Today
21.8.2013EP application
6.10.2021EP Publication
21.12.2021Translation submitted
15.1.2022Registration published
20.8.2025Expires
Owner
Name:
Sage Therapeutics, Inc.Address:
215 First Street, Cambridge, MA 02142, US
Inventor
Name:
REDDY, KiranAddress:
Boston, MA 02114, US
Name:
KANES, Stephen JayAddress:
Swarthmore, PA 19081, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261691545 PDate:
21.8.2012Country:
US
Number:
201361789491 PDate:
15.3.2013Country:
US
Classification
Categories:
A61K 31/57, A61K 45/06, A61P 25/08, A61P 25/10, A61P 25/12, A61P 23/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 5.7.2022
Expires: 20.8.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.7.2023
Expires: 20.8.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.7.2023
Expires: 20.8.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.7.2024
Expires: 20.8.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.7.2024
Expires: 20.8.2025
Payer: Árnason Faktor ehf.